Clinical trial
Treatment of Posttraumatic Swelling and Pain With Zhi Kang Capsule: a Multicenter, Phase IV Clinical Trial
NCT03363971 is registered in ClinicalTrials.gov with Peking University People's Hospital as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Treatment of Posttraumatic Swelling and Pain With Zhi Kang Capsule: a Multicenter, Phase IV Clinical Trial
- Lead sponsor
- Peking University People's Hospital
- Phase
- Phase 4
- Overall status
- Unknown status
- Start date
- March 13, 2017
- Completion date
- March 13, 2018
- Enrollment
- 2,200 (estimated)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.